Fernando Campos
@_camposfernando
Medical Oncologist. Sarcoma. Breast Cancer. AC Camargo Cancer Center - Sao Paulo, Brazil.
ID: 1123757324408184832
02-05-2019 01:13:19
27 Tweet
176 Followers
168 Following
Publicado na Cancers, estudo multicêntrico liderado pelos oncologistas Elizabeth Santana e Fernando Campos, do A.C.Camargo Cancer Center, realiza uma revisão do conhecimento atual da base genética da linhagem germinativa do CA mama masculino - tinyurl.com/3haaymt8
Great honor to participate in this fantastic event organized by #tumordesmoidebrasil. September is the Desmoid awareness month! Let’s support our patients! Desmoid Foundation ONLUS - Italia Sarcoma European LatinAmerican Network (SELNET) SBOC Sociedade Brasileira de Cirurgia Oncológica (SBCO) A.C.Camargo Cancer Center
In this study, we identified a high prevalence of CTCs in pts with desmoid tumor, with concordance of β-catenin expression between primary tumor and the CTCs, which can open new avenues for studying the biology and behavior of DT. Celso Mello ludmilla td chinen frontiersin.org/article/10.338…
Initial active surveillance strategy confirmed as preferred strategy for patients with #desmoids #fibromatosis phase II trial by sylvie bonvalot Réseau de référence sarcomes NETSARC+ ORR >30% without treatment We can spare most of the patients from surgery! #ESMO21 ESMO - Eur. Oncology OncoAlert #sarcoma
New article! 🗣️📣 The SELNET clinical practice guidelines for #STS and #GIST Here the link for free access authors.elsevier.com/c/1e5Pv15X3~Sz… Jean-Yves Blay Nadia Hindi Fernando Campos Dr JMartín-Broto Paolo G Casali Paolo Dei Tos Dr. Tomás Soulé Emanuela Palmerini Celso Mello Alessandro Gronchi Eduardo Ortiz Cruz
Why the combination of ifosfamide and etoposide as a salvage regimen for previously treated soft tissue sarcomas should not be used Fernando Campos Celso Mello Sarcoma European LatinAmerican Network (SELNET) ecancer.org/en/journal/art…
Press release results - new drug for a rare sarcoma 👉🏼 Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase 3 DeFi Trial in Adult Patients with Progressing Desmoid Tumors | BioSpace Jon Trent, MD, PhD Anthony P Conley biospace.com/article/releas…
Great discussions on today’s Sarcoma Session from AC Camargo A.C.Camargo Cancer Center Meeting “Next Frontiers to Cure Cancer”. Dr. Tomás Soulé Celso Mello Vinod Ravi, MD Salvatore Provenzano Dorian Y. García-Ortega MD, MSc,PhD, FACS
Just chaired the session on H&N Sarcomas in the Next Frontiers to Cure Cancer A.C.Camargo Cancer Center . No better way to finish the sarcoma agenda than with the great talk by Emanuela Palmerini , and interesting case discussion with my colleagues from AC Camargo.
First day at #CTOS was amazing. Had the privilege to bump into my Brazilian sarcoma colleagues! Priscila Barreto Coelho, MD Roberto Pestana, MD Fernando Campos
It’s out! This guideline JAMA Oncology #desmoid reflects our multidisciplinary global collaboration, highlights new treatment strategies &importance of quality of life. Thanks Bernd Kasper, Alessandro Gronchi, pts, all. Current Management of Desmoid Tumors: A Review. pubmed.ncbi.nlm.nih.gov/38900421/